5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science

News
2023
2022
Archive

March 23, 2023

5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science
March 23, 2023

Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO (Rezagungin for Injection) for the Treatment of Candidemia and Invasive Candidiasis
March 9, 2023

Homology Medicines Announces Promotion of Julie Jordan, M.D., to Chief Medical Officer
March 6, 2023

Rallybio Announces Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
March 2, 2023

Expansion Therapeutics Announces Key Additions and Updates to Scientific Advisory Board
March 1, 2023

Cidara Therapeutics Announces Promising Interim Phase 2a Data Assessing the Safety and Efficacy of a Single Dose of CD388 in an Influenza Challenge Model
February 27, 2023

Escient Pharmaceuticals Announces Oral Presentation of Data Highlighting the Preclinical Pharmacology of EP262 at the American Academy of Allergy, Asthma and Immunology Annual Meeting
February 27, 2023

EyePoint and Rallybio Announce Research Collaboration to Evaluate Rallybio’s Inhibitor of Complement Component 5 (C5) and EyePoint’s Proprietary Durasert® Technology for Sustained Intraocular Delivery in Geographic Atrophy
February 24, 2023

Enliven Therapeutics Closes Merger with Imara and Private Placement of $165 Million
February 22, 2023

Homology Medicines Presents Preclinical Data Supporting Immunosuppression Regimen in Ongoing PKU and Hunter Syndrome Clinical Trials, and Details Optimized MLD Gene Therapy Candidate at the 19th Annual WORLDSymposium™ Meeting

1
2
3
…
107
Next Page »

© 2023 5AM Venture Management LLC